Allergan receives FDA approval for Ozurdex® treatment option for use in certain patients with diabetic macular edema
Allergan, Inc., has announced that the U.S. Food and Drug Administration (FDA) has approved OZURDEX® as a new treatment option for diabetic macular edema (DME) in adult patients who have an...